Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16730097rdf:typepubmed:Citationlld:pubmed
pubmed-article:16730097lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:16730097lifeskim:mentionsumls-concept:C0382336lld:lifeskim
pubmed-article:16730097lifeskim:mentionsumls-concept:C0009647lld:lifeskim
pubmed-article:16730097lifeskim:mentionsumls-concept:C0039593lld:lifeskim
pubmed-article:16730097lifeskim:mentionsumls-concept:C0022885lld:lifeskim
pubmed-article:16730097lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:16730097lifeskim:mentionsumls-concept:C0205250lld:lifeskim
pubmed-article:16730097pubmed:issue9lld:pubmed
pubmed-article:16730097pubmed:dateCreated2006-8-15lld:pubmed
pubmed-article:16730097pubmed:abstractTextDifferent reports suggest that nociceptin/orphanin FQ (N/OFQ) may have either anxiolytic- or anxiogenic-like effect in rodents. Since N/OFQ elicits hypolocomotion, which undergoes rapid tolerance, and hypolocomotion may be associated to emotional consequences, the present study was designed to investigate the effect of N/OFQ on anxiety after development of tolerance to its hypolocomotor effect. The effect of single or double intracerebroventricular (i.c.v.) injection of N/OFQ was evaluated on anxiety-related behaviors in rats, in the elevated plus maze (EPM) and conditioned defensive burying (CDB) tests. After single administration, N/OFQ displayed an anxiogenic-like pattern of response on the elevated plus maze but hypolocomotion was also observed. Conversely, in the CDB test, N/OFQ induced a clear-cut anxiolytic pattern. To produce tolerance to N/OFQ-induced hypolocomotion the peptide was administered by two i.c.v. injections separated by 120 min; in these conditions it decreased the expression of anxiety-related behaviors in both tests without affecting locomotor activity. The nociceptin/orphanin FQ peptide (NOP) receptor antagonist UFP-101 significantly reduced the effects of N/OFQ to control values in either tests. Corticosterone levels were significantly increased after a single N/OFQ administration (not in a dose-dependent manner) but this increase did not reach significance after double administration (1 nmol/rat). Our results support the idea that N/OFQ may act as an anxiolytic-like agent in the rat; the apparent anxiogenic-like effect observed following its single administration in the EPM may be consequent to its effect on locomotion.lld:pubmed
pubmed-article:16730097pubmed:languageenglld:pubmed
pubmed-article:16730097pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16730097pubmed:citationSubsetIMlld:pubmed
pubmed-article:16730097pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16730097pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16730097pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16730097pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16730097pubmed:statusMEDLINElld:pubmed
pubmed-article:16730097pubmed:monthSeplld:pubmed
pubmed-article:16730097pubmed:issn0196-9781lld:pubmed
pubmed-article:16730097pubmed:authorpubmed-author:MassiMaurizio...lld:pubmed
pubmed-article:16730097pubmed:authorpubmed-author:GiovanniVital...lld:pubmed
pubmed-article:16730097pubmed:authorpubmed-author:ArlettiRossan...lld:pubmed
pubmed-article:16730097pubmed:authorpubmed-author:CifaniCarloClld:pubmed
pubmed-article:16730097pubmed:authorpubmed-author:RuggieriValen...lld:pubmed
pubmed-article:16730097pubmed:issnTypePrintlld:pubmed
pubmed-article:16730097pubmed:volume27lld:pubmed
pubmed-article:16730097pubmed:ownerNLMlld:pubmed
pubmed-article:16730097pubmed:authorsCompleteYlld:pubmed
pubmed-article:16730097pubmed:pagination2193-200lld:pubmed
pubmed-article:16730097pubmed:meshHeadingpubmed-meshheading:16730097...lld:pubmed
pubmed-article:16730097pubmed:meshHeadingpubmed-meshheading:16730097...lld:pubmed
pubmed-article:16730097pubmed:meshHeadingpubmed-meshheading:16730097...lld:pubmed
pubmed-article:16730097pubmed:meshHeadingpubmed-meshheading:16730097...lld:pubmed
pubmed-article:16730097pubmed:meshHeadingpubmed-meshheading:16730097...lld:pubmed
pubmed-article:16730097pubmed:meshHeadingpubmed-meshheading:16730097...lld:pubmed
pubmed-article:16730097pubmed:meshHeadingpubmed-meshheading:16730097...lld:pubmed
pubmed-article:16730097pubmed:meshHeadingpubmed-meshheading:16730097...lld:pubmed
pubmed-article:16730097pubmed:meshHeadingpubmed-meshheading:16730097...lld:pubmed
pubmed-article:16730097pubmed:meshHeadingpubmed-meshheading:16730097...lld:pubmed
pubmed-article:16730097pubmed:meshHeadingpubmed-meshheading:16730097...lld:pubmed
pubmed-article:16730097pubmed:meshHeadingpubmed-meshheading:16730097...lld:pubmed
pubmed-article:16730097pubmed:meshHeadingpubmed-meshheading:16730097...lld:pubmed
pubmed-article:16730097pubmed:year2006lld:pubmed
pubmed-article:16730097pubmed:articleTitleAnxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats.lld:pubmed
pubmed-article:16730097pubmed:affiliationDepartment of Biomedical Sciences, Section of Pharmacology, University of Modena and Reggio Emilia, I-41100 Modena, Italy. vitale.giovanni@unimore.itlld:pubmed
pubmed-article:16730097pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16730097lld:pubmed